MRK MERCK & CO. INC.
2026Q1 · CUSIP 58933Y105 · Big Pharma · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
3,719
Δ holders QoQ
+130
Breadth percentile
Top 1%
Whale holders
366
Δ whales
+4
Inst. holding value
$224.7B
New positions
324
Closed positions
194
Price momentum (1Q)
-6.7%
Put / Call
52/50
Breadth history (34 quarters)
Past Lit Events & Aftermath 20 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 1% | — | — |
| 2025Q4 | Top 0% | -6.7% | — |
| 2024Q4 | Top 3% | -6.5% | +3.9% |
| 2024Q1 | Top 1% | -12.3% | -25.7% |
| 2023Q4 | Top 1% | +3.3% | -9.4% |
| 2023Q2 | Top 1% | -5.4% | +18.0% |
| 2022Q4 | Top 0% | +7.8% | +3.9% |
| 2022Q2 | Top 1% | +11.7% | +20.6% |
Options Sentiment
Put holders
52
QoQ: +4
Call holders
50
QoQ: -3
See methodology →
Fundamentals
PE (TTM)
33.9
EPS (TTM)
$3.55
EPS YoY
-48.4%
Revenue (TTM)
$65.8B
Revenue YoY
+2.9%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)